Subcutaneous Apomorphine
- 1 January 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 21 (11), 687-709
- https://doi.org/10.2165/00002512-200421110-00001
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor SubtypesThe Journal of pharmacology and experimental therapeutics, 2002
- Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson??s DiseaseClinical Pharmacokinetics, 2002
- Are Dopamine Receptor Agonists Neuroprotective in Parkinson??s Disease?Drugs & Aging, 2001
- Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Concentration-Effect Relationship of Levodopa in Patients with Parkinson's DiseaseClinical Pharmacokinetics, 1995
- Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Current Status of Dopamine Agonists in Parkinson??s Disease ManagementDrugs, 1993
- The short-duration response to apomorphine: Implications for the mechanism of dopaminergic effects in parkinsonismAnnals of Neurology, 1990
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- III. Researches into the chemical constitution of the opium bases. Part I.—On the action of hydrochloric acid on morphiaProceedings of the Royal Society of London, 1869